Vemlidy 25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F0WM6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,789
Award facts
- Contract value 100% obligated
- $3,788.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a ceiling value of $3,788.81 and an ultimate completion date of November 12, 2025. This non-competitive, firm fixed-price delivery order was issued without a set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in hepatitis B treatment, representing part of the broader pharmaceutical supply requirements supported through federal medical procurement channels.
This delivery order is issued under AmerisourceBergen Drug Corp's parent Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a wide range of medications and medical commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's extensive portfolio of competitively awarded federal contracts demonstrates its capability to fulfill complex medical supply requirements across multiple therapeutic domains for the Department of Defense health system.
Quick answers
Who was awarded contract SPE2DR26F0WM6?
SPE2DR26F0WM6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26F0WM6 worth?
The government has obligated $3,789 on SPE2DR26F0WM6.
Is contract SPE2DR26F0WM6 an order under another contract?
Yes. SPE2DR26F0WM6 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0WM6 competed?
The extent of competition for SPE2DR26F0WM6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award